SPARK, a program originating from Stanford University (U.S.A.), is dedicated to providing a nurturing environment for the development of biomedical talent in new drug and medical device innovation. It targets educators and physicians who are either interested in or already working on drug or medical device development but lack commercialization expertise. The program offers essential training in areas such as translational research, regulatory affairs, intellectual property and negotiations, marketing, and business planning. Additionally, it supports team leaders in the R&D and commercialization of new drugs and medical devices.

SPARK offers a comprehensive series of courses and professional mentorship for training teams, supplemented with development funding. The program aims to help teams reach milestones such as entering clinical trials, technology transfer, or integration into larger projects. The goal is to cultivate talent with a global perspective in drug and medical device development, and to promote the commercialization of research and development outcomes.

Fu Jen Catholic University is one of the key universities designated by the National Science and Technology Council (NSTC) for the SPARK TAIWAN program. In collaboration with the National Taiwan University of Science and Technology, the university jointly implements the program, having trained more than 50 biomedical teams and over 400 participants from academia, research institutions, and the medical sector. The program focuses on transforming innovative technologies into practical value and commercializing research and development outcomes.